Egypt PCR-based Infectious Diseases Market to 2032

Overview

The Egypt PCR-based Infectious Diseases Market is expected to reach a 99.47 USD Million by 2032 and is projected to grow at a CAGR of 5.00% from 2025 to 2032.

Revenue, 2024 (USD Million)
72.16
Forecast, 2032 (USD Million)
99.47
CAGR, 2024 - 2032
5.00%
Report Coverage
Egypt

Egypt PCR-based Infectious Diseases Market 2018-2032 USD Million

Egypt PCR-based Infectious Diseases Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 72.16 USD Million
  • Projected Market Size (2032): 99.47 USD Million
  • CAGR (2025-2032): 5.00%

Key Findings of Egypt PCR-based Infectious Diseases Market

  • The Egypt PCR-based Infectious Diseases Market was valued at 72.16 USD Million in 2024.
  • The Egypt PCR-based Infectious Diseases Market is likely to grow at a CAGR of 5.00% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 45.78 USD Million
  • The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 6.99% during the forecast period from 2024 to 2032.

Egypt PCR-based Infectious Diseases Market Scope

Egypt PCR-based Infectious Diseases Market Segmentation & Scope
Test Type
  • Others PCR Test
  • Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
  • Mycoplasma Genitalium (Mg) PCR Test
  • Enterococcus PCR Test
  • Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
  • C.Difficile (Clostridium Difficile) PCR Test
  • Norovirus PCR Test
  • Sars (Covid-19) PCR Test
  • H. Pylori PCR Test
  • Bordetella PCR Test
  • Rotavirus PCR Test
  • Salmonellosis PCR Test
  • Gonorrhea PCR Test
  • Chlamydia Trachomatis Genital PCR Test
  • Human Papillomavirus (Hpv) PCR Test
  • Influenza PCR Test
  • Human Immunodeficiency Virus (Hiv) PCR Test
  • Hepatitis PCR Test
  • Tuberculosis PCR Test
End User
  • Others
  • Home Healthcare
  • Academic And Research Institutes
  • Community Health Centers
  • Clinics
  • Hospital
  • Diagnostic Centers
Testing
  • Point of Care Testing
  • Laboratory Based Testing
Patient Type
  • Adults
  • Pediatric
  • Geriatric
PCR Technology
  • Others
  • Multiplex PCR
  • RT PCR
Pathogen
  • Others
  • Protozoa
  • Fungal
  • Bacterial
  • Viral
Infection
  • Other Infections
  • Hospital Acquired Infections
  • Sexually Transmitted infection
  • Respiratory Tract Infection
  • Viral Infection

Egypt PCR-based Infectious Diseases Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 72.16 USD Million
Market Value in 2032 99.47 USD Million
CAGR (2025-2032) 5.00%
Historic Data 2016-2023
Market Segments Covered Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection

Regional Insights:

  • Leading Market (2024-2032): Egypt, leading in terms of revenue 72.16 USD Million in 2024
    • Key Country: Egypt, leading in terms of revenue with value of 72.16 USD Million in 2024.

Segments and Scope

  • Egypt PCR-based Infectious Diseases Market to 2032, By Test Type
    • Tuberculosis PCR Test is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 11.63 USD Million in the year 2024.
    • Tuberculosis PCR Test is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 6.99 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By End User
    • Diagnostic Centers is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 21.13 USD Million in the year 2024.
    • Diagnostic Centers is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 6.51 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By Testing
    • Laboratory Based Testing is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 45.78 USD Million in the year 2024.
    • Laboratory Based Testing is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.26 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By Patient Type
    • Geriatric is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 31.45 USD Million in the year 2024.
    • Geriatric is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.72 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By PCR Technology
    • RT PCR is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 32.27 USD Million in the year 2024.
    • RT PCR is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.74 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By Pathogen
    • Viral is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 31.26 USD Million in the year 2024.
    • Viral is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.35 % in forecast period 2025-2032.
  • Egypt PCR-based Infectious Diseases Market to 2032, By Infection
    • Viral Infection is the largest segment in Egypt PCR-based Infectious Diseases Market to 2032 with a revenue of 32.56 USD Million in the year 2024.
    • Viral Infection is the Fastest growing segment in Egypt PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.60 % in forecast period 2025-2032.

Egypt PCR-based Infectious Diseases Market Company Share Analysis

 
Egypt PCR-based Infectious Diseases Market Company Share Analysis
Egypt PCR-based Infectious Diseases Market Company Share Analysis

Egypt PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million

Egypt PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million

Egypt PCR-based Infectious Diseases Market Company Profiling

Egypt PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The Egypt PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
Egypt PCR-based Infectious Diseases Market was valued at USD 72.16(Revenue in USD Million) in 2022.
Egypt PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.00% during the forecast period of 2024 to 2032.
The Laboratory Based Testing segment is expected to dominate the Egypt PCR-based Infectious Diseases Market, holding a largest market share of 45.78 USD Million in 2024

Egypt PCR-based Infectious Diseases Market Scope

Egypt PCR-based Infectious Diseases Market Segmentation & Scope
Test Type
  • Others PCR Test
  • Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
  • Mycoplasma Genitalium (Mg) PCR Test
  • Enterococcus PCR Test
  • Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
  • C.Difficile (Clostridium Difficile) PCR Test
  • Norovirus PCR Test
  • Sars (Covid-19) PCR Test
  • H. Pylori PCR Test
  • Bordetella PCR Test
  • Rotavirus PCR Test
  • Salmonellosis PCR Test
  • Gonorrhea PCR Test
  • Chlamydia Trachomatis Genital PCR Test
  • Human Papillomavirus (Hpv) PCR Test
  • Influenza PCR Test
  • Human Immunodeficiency Virus (Hiv) PCR Test
  • Hepatitis PCR Test
  • Tuberculosis PCR Test
End User
  • Others
  • Home Healthcare
  • Academic And Research Institutes
  • Community Health Centers
  • Clinics
  • Hospital
  • Diagnostic Centers
Testing
  • Point of Care Testing
  • Laboratory Based Testing
Patient Type
  • Adults
  • Pediatric
  • Geriatric
PCR Technology
  • Others
  • Multiplex PCR
  • RT PCR
Pathogen
  • Others
  • Protozoa
  • Fungal
  • Bacterial
  • Viral
Infection
  • Other Infections
  • Hospital Acquired Infections
  • Sexually Transmitted infection
  • Respiratory Tract Infection
  • Viral Infection
Frequently Asked Questions
The Egypt PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
Egypt PCR-based Infectious Diseases Market was valued at USD 72.16(Revenue in USD Million) in 2022.
Egypt PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.00% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt PCR-based Infectious Diseases Market for final year is USD 99.47 (USD Million).

Egypt PCR-based Infectious Diseases Market Company Profiling

Egypt PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The Egypt PCR-based Infectious Diseases Market is segmented based on Segmentation Test Type,End User,Testing,Patient Type,PCR Technology,Pathogen,Infection.
Egypt PCR-based Infectious Diseases Market was valued at USD 72.16(Revenue in USD Million) in 2022.
Egypt PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.00% during the forecast period of 2024 to 2032.
The estimated market value of the Egypt PCR-based Infectious Diseases Market for final year is USD 99.47 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.